Osterweis Capital Management’s Eli Lilly LLY Stock Holding History

Osterweis Capital Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$41.2M	Buy	44,788 +10	+0%	+$10.1K	2.12%	13
2025 Q4	$48.1M	Sell	44,778 -3,204	-7%	-$3.06M	2.04%	13
2025 Q3	$36.6M	Buy	47,982 +36,555	+320%	+$27.2M	1.65%	22
2025 Q2	$8.91M	Buy	11,427 +222	+2%	+$173K	0.43%	61
2025 Q1	$9.25M	Sell	11,205 -40	-0.4%	-$33.3K	0.46%	68
2024 Q4	$8.68M	Hold	11,245	–	–	0.4%	75
2024 Q3	$9.96M	Sell	11,245 -240	-2%	-$216K	0.5%	61
2024 Q2	$10.4M	Sell	11,485 -713	-6%	-$570K	0.54%	53
2024 Q1	$9.49M	Sell	12,198 -900	-7%	-$641K	0.56%	47
2023 Q4	$7.64M	Sell	13,098 -586	-4%	-$342K	0.48%	59
2023 Q3	$7.35M	Hold	13,684	–	–	0.54%	55
2023 Q2	$6.42M	Sell	13,684 -650	-5%	-$273K	0.42%	68
2023 Q1	$4.92M	Sell	14,334 -276	-2%	-$93.1K	0.33%	78
2022 Q4	$5.34M	Sell	14,610 -56	-0.4%	-$19.9K	0.39%	73
2022 Q3	$4.74M	Sell	14,666 -950	-6%	-$301K	0.36%	73
2022 Q2	$5.06M	Hold	15,616	–	–	0.38%	72
2022 Q1	$4.47M	Hold	15,616	–	–	0.25%	92
2021 Q4	$4.31M	Hold	15,616	–	–	0.22%	91
2021 Q3	$3.61M	Hold	15,616	–	–	0.2%	97
2021 Q2	$3.58M	Sell	15,616 -71	-0.5%	-$14.3K	0.18%	105
2021 Q1	$2.93M	Hold	15,687	–	–	0.16%	103
2020 Q4	$2.65M	Sell	15,687 -8,188	-34%	-$1.22M	0.16%	95
2020 Q3	$3.53M	Hold	23,875	–	–	0.24%	82
2020 Q2	$3.92M	Hold	23,875	–	–	0.28%	79
2020 Q1	$3.31M	Hold	23,875	–	–	0.27%	70
2019 Q4	$3.14M	Sell	23,875 -55	-0.2%	-$6.38K	0.22%	75
2019 Q3	$2.68M	Buy	23,930 +291	+1%	+$32.4K	0.2%	77
2019 Q2	$2.62M	Hold	23,639	–	–	0.19%	79
2019 Q1	$3.07M	Hold	23,639	–	–	0.19%	81
2018 Q4	$2.74M	Sell	23,639 -1,000	-4%	-$112K	0.21%	75
2018 Q3	$2.64M	Hold	24,639	–	–	0.17%	85
2018 Q2	$2.1M	Hold	24,639	–	–	0.14%	86
2018 Q1	$1.91M	Hold	24,639	–	–	0.14%	80
2017 Q4	$2.08M	Hold	24,639	–	–	0.15%	80
2017 Q3	$2.11M	Hold	24,639	–	–	0.16%	71
2017 Q2	$2.03M	Hold	24,639	–	–	0.15%	70
2017 Q1	$2.07M	Hold	24,639	–	–	0.16%	65
2016 Q4	$1.81M	Hold	24,639	–	–	0.13%	63
2016 Q3	$1.98M	Buy	24,639 +8,188	+50%	+$655K	0.12%	55
2016 Q2	$1.3M	Hold	16,451	–	–	0.08%	58
2016 Q1	$1.19M	Buy	+16,451	New	+$1.24M	0.07%	59
2015 Q4	–	Sell	-16,451	Closed	-$1.38M	–	58
2015 Q3	$1.38M	Hold	16,451	–	–	0.06%	45
2015 Q2	$1.37M	Hold	16,451	–	–	0.05%	48
2015 Q1	$1.2M	Hold	16,451	–	–	0.04%	47
2014 Q4	$1.14M	Hold	16,451	–	–	0.04%	50
2014 Q3	$1.07M	Hold	16,451	–	–	0.03%	47
2014 Q2	$1.02M	Hold	16,451	–	–	0.03%	49
2014 Q1	$968K	Hold	16,451	–	–	0.03%	51
2013 Q4	$839K	Sell	16,451 -180	-1%	-$9.01K	0.03%	58
2013 Q3	$829K	Hold	16,631	–	–	0.03%	56
2013 Q2	$817K	Buy	+16,631	New	+$905K	0.03%	52

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Osterweis Capital Management's LLY Position: Q1 2026 in Review

Osterweis Capital Management increased its Eli Lilly (LLY) stake by 0.02% in Q1 2026, buying an estimated $10.1K and bringing the position to 44,788 shares worth $41.2M. The position accounts for 2.12% of the portfolio, ranked #13.

Osterweis Capital Management first reported a position in LLY in Q2 2013 and has held it in 51 quarters since. The position peaked at $48.1M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

Osterweis Capital Management held 44,788 shares of Eli Lilly worth $41.2M as of Q1 2026.
Osterweis Capital Management bought 10 Eli Lilly shares in Q1 2026, an estimated $10.1K.
Eli Lilly made up 2.12% of Osterweis Capital Management's portfolio in Q1 2026, its #13 holding.
Osterweis Capital Management first reported a position in Eli Lilly in Q2 2013 and has held it in 51 quarters since.
Osterweis Capital Management's Eli Lilly position peaked at $48.1M in Q4 2025.
4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Osterweis Capital Management's 13F filing for Q1 2026, filed 15 May 2026.